Bixiye
Upcoming-med-policies-effective-April-5-2021.pdf
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2051 - 2060 ee natiijooyinka 3563
Bixiye
QP5-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Sucraid® (sacrosidase) PAQL
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2021
Bixiye
QP7-21 Replacement Claim Submission Guidelines
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2021
Bixiye
QP6-21 MHCP Pharmacy Benefit Exclusion for OxlumoTM and Danyelza®
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2021
Bixiye
QP8-21 Change in Suspect COVID-19 Diagnosis Code
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2021
Bixiye
QP4-21 Commercial Pharmacy Benefit Exclusion for OxlumoTM
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2021
Adeegyada Shaqaalaha
Blue-Cross-Connect-Okta-Account-Setup-Q1-2021.pdf
Sharciga & Xeerar
Annaga Nagu Saabsan
Notice of Nondiscrimination and Accessibility